期刊文献+

Investigation of Calcitonin and Calcitonin Gene-related Peptide in 88 Cases of Medullary Thyroid Carcinoma

甲状腺髓样癌降钙素及其基因相关肽检测的临床意义——附88例报告(英文)
下载PDF
导出
摘要 Objective: To investigate the changes of calcitonin (CT) and calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma (MTC). Methods: Fifty-eight cases of MTC were selected and the relationship between the CT levels and metastasis was investigated. The immunohistochemical method was used to detect the expression of CT and CGRP in the 58 samples of MTC tissues. The CT and CGRP in 30 newly diagnosed MTC inpatients were measured before operation and in the first few days after operation using a radioimmunoassy. Results: (1) The rate of residual tumor had a significant difference between the normal serum CT group one month after operation and the elevated group at the same period (P〈0.01). (2) Immunohistochemical study revealed the positive rate of CT was about 98%, and that of the CGRP was 87.8%. (3) Part of the patients had an elevated CGRP levels while CT levels was normal. (4) The serum CT levels were decreased to a stable range one week after operation. Conclusion: CT is a useful index to evaluate the efficacy of surgical treatment. The measurement of serum CGRP is helpful in the diagnosis of MTC, especially for those whose preoperative CT levels are normal.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第6期344-346,共3页 中德临床肿瘤学杂志(英文版)
基金 This project was supported by a grant from the Natural Science Foundation from Tianjin Government.
关键词 CALCITONIN calcitonin gene-related peptide medullary thyroid carcinoma 降血钙素 基因相关肽 脊髓肿瘤 甲状腺肿瘤
  • 相关文献

参考文献3

二级参考文献12

  • 1[1]Wells SA Jr, Franz C. Medullary Carcinoma of the thyroid gland[J].World J Surg,2000,24(8):952 - 956.
  • 2[2]Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors:a commentary on the second edition[J]. Cancer, 1989,63(5):908 - 911.
  • 3[3]Us Krasovec M,Auersperg M, Bergant D,et al. Medullary carcinoma of the thyroid gland: diagnostic cytopathological characteristics [J].Pathologica, 1998,90(1): 5 - 13.
  • 4[4]Kasprzak A, Zabel M, Surdyk Zasada J, et al. Hybridocytochemical detection of mRNA for calcitonin, cGRP, somatostatin and NPY in cultured cells of medullary thyroid carcinoma using immunomax technique[J]. Folia Histochem Cytobiol, 1999,37(2):59 - 60.
  • 5Gimm O, Ukkat J ,Dralle H, et al. Determninative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma[J]. World J Surg, 1998,22(6) :562.
  • 6Samaan N, Schultz P, Hickey R. Medullary thyroid carcinoma:Prognosis of familial versus sporadic disease and the role of radiotherapy[J ]. Medicine, 1988,67 : 801.
  • 7Jensen MH, Davis RK,Derrick L. Thyroid cancer: A computer-assisted review of 5287 cases[J]. Otolaryngol Head Neck Surg,1990,102 : 51.
  • 8Brierley J,Tsang R,Simpson WJ,et al. Medullary thyroid cancer analyses of survival and prognostic factors and the role of radiation therapy in local control[J ]. Thyroid, 1996.6: 305.
  • 9Sarrazin D, Fontaine F, Rougier P, et al. Role of radiotherapy in the treatment of medullary cancer of the thyroid [J ], Bull cancer,1984,71(3) :200.
  • 10Shimaoka K, Schoenfeld DA, Dewys WD, et al. A Randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma[J]. Cancer, 1985,55:2155.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部